Phase II clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer Cancer Medicine June 2024;13(12)
Date
06/01/2024
DOI
10.1002/cam4.7412Scopus ID
2-s2.0-85196660360 (requires institutional sign-in at Scopus site)
5 CitationsAuthor List
Jameson GS, Hosein PJ, Pierce E, Kamgar M, Gordon MS, Snyder C, Roe DJ, Wertheim BC, Davey M, Barrett MT, Von Hoff DD, Borazanci E
Author
Mandana Kamgar MPH, MD Associate Professor in the Medicine department at Medical College of Wisconsin